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Actin cytoskeletonAurora A kinase regulates early mitotic events through phosphorylation and activation of a variety of proteins.
Speciﬁcally, Aur-A is involved in centrosomal separation and formation of mitotic spindles in early prophase.
The effect of Aur-A on mitotic spindles is mediated by the modulation of microtubule dynamics and association
with microtubule binding proteins. In this study we show that Aur-A exerts its effects on spindle organization
through the regulation of the actin cytoskeleton. Aurora A phosphorylates Coﬁlin at multiple sites including S3
resulting in the inactivation of its actin depolymerizing function. Aur-A interacts with Coﬁlin in early mitotic
phases and regulates its phosphorylation status. Coﬁlin phosphorylation follows a dynamic pattern during
the progression of prophase to metaphase. Inhibition of Aur-A activity induced a delay in the progression of
prophase to metaphase. Aur-A inhibitor also disturbed the pattern of Coﬁlin phosphorylation, which correlated
with the mitotic delay. Our results establish a novel function of Aur-A in the regulation of actin cytoskeleton
reorganization, through Coﬁlin phosphorylation during early mitotic stages.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Aurora A (Aur-A) is a member of the family of Aurora serine/
threonine kinases, which play important roles in the mitotic process.
Expression of Aur-A is signiﬁcantly increased during late G2 when it is
targeted to the centrosomes. Aur-A is responsible for centrosomal
maturation and separation by recruiting α-tubulin, centrosomin,
NDEL1, TACC, and LATS2 to the centrosomes [1–4]. Aur-A also regulates
mitotic spindle assembly through interactions with LIMK1, TPX2, Eg5,
Hurp, and XMAP215 [5–8]. Although the function of Aur-A is essential
during early prophase, spindle pole localization of Aur-A is sustained
through the mitotic phases, suggesting its involvement in later mitotic
events. Recent studies showed a cooperative function of Aur-A and
Aur-B on anaphasemicrotubule dynamics [9]. Aur-A expression is tight-
ly regulated and altered expression of Aur-A results in mitotic spindle
defects. Inhibition of Aur-A expression resulted in chromosome mis-
alignment and multinucleated cells [10], whereas overexpression of
Aur-A induced generation of supernumerary centrosomes, multipolar
spindles, and aneuploidy. Importantly, overexpression of Aur-A is seen
a variety of cancers including, breast, ovarian and prostate [11,12],
which may lead to the development of aneuploidy in the cancerous
cells.ay, Orlando, FL 32826, USA.
arti).In addition to its regulation of microtubule dynamics and chromo-
some segregation duringmitosis, Aur-A has been implicated in the reg-
ulation of actin cytoskeleton. Activation of Drosophila Aur-A has been
suggested to play a role in actin dependent asymmetric protein
localization during mitosis [13]. Overexpression of Aur-A was shown
to induce the up-regulation of SSH-1 leading to dephosphorylation
and activation of the actin depolymerizing protein, Coﬁlin [14]. Aur-A
also interacts with LIMK1 and Ajuba, proteins that are involved in the
reorganization of the actin cytoskeleton [8,15]. Recent studies showed
an indirect relationship between Aur-A and regulation of actin-
dependent processes through phosphorylation of Rho kinases in Dro-
sophila [16]. Nonetheless, the role of Aur-A regulation of the actin
cytoskeleton has not been clearly deﬁned.
Although not widely studied, actin has an important function
throughout mitosis. During G2 phase, the actin cytoskeleton is involved
in centrosome separation [17,18]. Cortical actin plays a role in the
anchoring and orientation of the mitotic spindle [19,20]. Additionally,
the regulation of actin dynamics is essential for the completion of
cytokinesis through the formation of the contractile ring [21,22].
The dynamics of the actin cytoskeleton is regulated by the actin
depolymerizing protein, Coﬁlin. Kinases, such as LIMK1/2 and TESK1/
2, regulate Coﬁlin activity through phosphorylation, which prevents
its binding to actin [23–27]. However, functionally active Coﬁlin is
essential for the completion of cytokinesis. Also, LIMK1 mediated
inactivating phosphorylation of Coﬁlin during mitosis is necessary
for proper mitotic spindle orientation [28], however, the exact function
of Coﬁlin during mitosis has yet to be determined. In this study, we
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activity through phosphorylation, thereby regulating actin polymeriza-
tion. Additionally, we found that Aur-A is involved in the regulation of
Coﬁlin phosphorylation during mitosis.2. Materials and methods
2.1. Cell culture, G2/M phase enrichment, and transfection
PC-3 prostate cancer cells (ATCC)were cultured in F12HAMcontain-
ing 10% fetal bovine serum and 1% antibiotic/antimycotic. M12 prostate
cancer cells (a gift from JayWare) were cultured in RPMI containing 5%
fetal bovine serum, 10 ng/mL EGF, ITS mix (5 μg/mL insulin, 5 μg/mL
transferrin, 5 ng/ml selenium), 50 μg/mL gentamycin, and 0.1 μMdexa-
methasone. NIH-3T3 cells (ATCC) were cultured in DMEM containing
10% fetal bovine serum and 1% antibiotic/antimycotic. MCF7 cells ob-
tained as a gift from James Turkson Univ. of Hawaii were cultured in
DMEMcontaining 10% fetal bovine serumand 1%antibiotic/antimycotic.
Cells were enriched at G2/M phase as follows: Cells were synchronized
at the G2/M boundary by treatment with nocodazole (3T3 600 ng/ml,
16 h; M12 80 ng/ml, 24 h). Synchronized cells were isolated by mitotic
shake off and released into mitotic phases using fresh complete media.
Cells were harvested at 0, 30, and 60 min after release. For experiments
with Aur-A inhibitor, M12 cells were treated with MLN8237 (100 nM),
BMS-5 (5 μM), both BMS-5 (5 μM) and MLN8237 (100 nM), or DMSO
for 24 h, then nocodazole was added for an additional 24 h. Cells were
collected by mitotic shake off and were released into mitosis with
fresh media containing MLN8237 (100 nM), BMS-5 (5 μM), BMS-5
(5 μM) and MLN8237 (100 nM), or DMSO and harvested at speciﬁc
time points. For ectopic expression of Coﬁlin, M12 cells were transfected
with Coﬁlin-RFP using X-tremeGENE HP (Roche) and used between 48
and 72 h.2.2. Inhibitors and antibodies
Speciﬁc inhibitors and reagents used were BMS-5 (Synkinase),
DMSO (Sigma), nocodazole (Sigma), MLN8237 (a gift from Selleck),
and VX-680 (a gift from Selleck). The primary and secondary antibodies
used were mouse anti-human-Aur-A (Sigma), rabbit anti-human-Coﬁlin
(Novus), rabbit anti-human-Coﬁlin (Pierce), rabbit anti-human-pS3-
Coﬁlin (Cell Signaling), mouse anti-human-GAPDH (Sigma), AlexaFluor-
488 Phalloidin (Molecular Probes), rabbit anti-human-pT505/T508-
LIMK1/2 (Cell Signaling), mouse anti-human-α-tubulin (Sigma), rabbit
anti-human-SSH1 (Cell Signaling), horseradish peroxidase (HRP) con-
jugated goat anti-rabbit (Jackson Laboratories), HRP conjugated
goat anti-mouse (Jackson, Laboratories), anti-mouse AlexaFluor-488
(Invitrogen) and anti-rabbit Cy3 (Jackson Laboratories).2.3. Immunoblotting and Immunoprecipitation
Cells were harvested by trypsinization and lysed with RIPA lysis
buffer. For immunoblots, 50 µg whole cell extracts were separated by
SDS-PAGE and proteins were transferred to a PVDF membrane. Speciﬁc
polypeptides were detected by reacting with the appropriate primary
and secondary antibodies and protein bands were visualized using a
substrate from an Immun-Star WesternC Kit (Biorad). For immunopre-
cipitates, 300 μg–500 μg whole cell extract was pre-cleared with
Sepharose A/G beads (Santa Cruz) overnight at 4 °C. Aur-A or Coﬁlin
was precipitated from the extract with 1.5 μg–2 μg Aur-A or Coﬁlin
antibody at 4 °C for 6 h. Mouse IgG or rabbit IgG was used as a control.
Protein–antibody complexes were pulled down with Sepharose A/G
beads at 4 °C overnight. Unbound protein was removed by washing
with RIPA buffer. Bound proteins were separated by SDS-PAGE and
Coﬁlin was detected by immunoblotting using anti-Coﬁlin antibodies.2.4. Recombinant protein production and puriﬁcation
The coding sequence of Coﬁlin was cloned into the pET-30 vector as
previously described [29], and in pCMV6-AC-RFP vector (Origene) to
generate His- and RFP-tagged Coﬁlin. Coﬁlin mutants (CoﬁlinS3A,
CoﬁlinS3A/S8A/T25A and CoﬁlinS3EE)were produced using theQuickChange
XL site-directed mutagenesis kit (Agilent). The truncated Coﬁlin con-
struct Coﬁlin90–166 was produced by PCR ampliﬁcation of the DNA frag-
ment containing bases 268–501 of the Coﬁlin ORF and cloning into the
pET-30 vector. The wild-type Aur-A and inactive Aur-AK162M mutant
were cloned into the pET-30 vector as previously described [8]. Recom-
binant Coﬁlin and Aur-A were expressed and puriﬁed as previously
described [8,29].
2.5. Kinase assays
For in vitro kinase assays, puriﬁed recombinant His-tagged proteins
were incubated in kinase assay buffer (50 mMMOPS pH 7.2, 25 mM β-
glycerophosphate, 10 mM EGTA, 4 mM EDTA, 50 mM MgCl2, 0.5 mM
DTT, 250 μMATP) and 5 nMγ-32P-ATP for 30min at room temperature.
The reactionwas stopped by the addition of Laemmli sample buffer and
proteins were separated by SDS-PAGE and stained with Coomassie
Brilliant Blue dye. Phosphorylation was detected by autoradiography.
For immunocomplex kinase assays, Aur-A was immunoprecipitated as
described above and Sepharose bead-bound protein–antibody com-
plexes were washed with kinase assay buffer. Beads were resuspended
in kinase assay buffer and the assay was performed as described above,
using recombinant His-Coﬁlin as the substrate.
2.6. Phosphopeptide analysis
Recombinant His-Aur-A or His-Aur-AK162M was incubated with
recombinant His-Coﬁlin in kinase assay buffer and cold ATP for
30 min at room temperature. Proteins were separated by SDS-PAGE
and the polypeptide bands were visualized by staining with
Coomassie Blue. Coﬁlin bands from both samples were excised
from the gel and used for LC MS/MS with titanium oxide enrichment
at the W.M. Keck Foundation Biotechnology Resource Laboratory
(Yale Cancer Center Mass Spectroscopy Resources) as previously de-
scribed [8].
2.7. Dual label immunoﬂuorescence
M12 cells (4 × 104) were seeded onto poly-L-lysine coated glass
coverslips and transfected with Coﬁlin-RFP constructs 24 h later as de-
scribed above. At 48 h post-transfection, cells were washed with PBS,
ﬁxed using 4% paraformaldehyde for 10 min at room temperature and
permeabilized with 4% paraformaldehyde containing 0.2% Tween-20
for 10 min at room temperature. Permeabilized cells were blocked
in blocking solution (10% goat serum, 0.2% Tween-20, 2% BSA in PBS)
for 90 min at room temperature. Cells were stained with Phalloidin for
F-actin, washed in sodium phosphate buffer and coverslips were
mountedwith DAPI Fluoromount G (Southern Biotech). For localization
of Coﬁlin in mitotic cells with or without treatment with Aur-A inhibi-
tor, M12 cells (3 × 104) were seeded onto poly-L-lysine coated cover-
slips and after 24 h treated with either 100 nM MLN8237 or DMSO
for an additional 24 h. Next, cells were synchronized at G2/M phase
and released into mitosis as described above. Coverslips were washed
with PBS and ﬁxed/permeabilized with 100% methanol for 10 min at
−20 °C. Coverslips were blocked and treated with anti-Coﬁlin and
anti-α-tubulin primary antibodies and anti-mouse AlexaFluor-488 and
anti-rabbit Cy3 secondary antibodies. Cells were counterstained with
DAPI and mounted as described above. For F-actin staining of MCF7
cells, 3 × 104 cells were seeded onto poly-L-lysine coated glass cover-
slips. Coverslipswerewashedwith PBS andﬁxedwith4%paraformalde-
hyde and permeabilized with 4% paraformaldehyde containing 0.2%
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and DAPI andmounted as described above. Positive signals were visual-
ized in a Leica TCS SP5II confocal microscope.
2.8. Actin polymerization assay
Pyrene labeled actin (cytoskeleton) was polymerized in the pres-
ence of polymerization buffer (2 mM MgCl2, 0.5 mM ATP, 0.2 M KCl,
pH 7.0) for 2 h at RT. The polymerized actin was then incubated with
His-Coﬁlin, His-CoﬁlinS3A, andHis-CoﬁlinS3A/S8A/T25A that had previously
been phosphorylated by Aur-A as described above for 10 min at room
temperature. F-actin was stained with Phalloidin in a microfuge tube
as described above and the actin/protein mixture was mounted on cov-
erslips. Actin ﬁlaments were visualized by confocal microscopy.
3. Results
3.1. Coﬁlin acts as a substrate of Aurora A
LIMK1/2 act as the bona-ﬁde kinases for inactivating phosphoryla-
tion of Coﬁlin [23] but treatment with BMS-5, a speciﬁc inhibitor of
LIMK1/2 catalytic activity did not completely inhibit Coﬁlin phosphory-
lation. Although a signiﬁcantly decreased phosphorylation of Coﬁlin
was noted after treatment with BMS-5 compared to the vehicle control,
DMSO (Fig. 1A) a small amount of phosphorylated Coﬁlin was still
detectable. This suggests that either the kinase activity of LIMK1 is
not completely blocked by BMS-5 or a different kinase, may be respon-
sible for Coﬁlin phosphorylation. In our previous studies we identiﬁed
a novel interaction between LIMK1 and Aur-A at the centrosomes [8],
which prompted us to investigate if Aur-A is responsible for the re-
maining Coﬁlin phosphorylation. To determine if Coﬁlin is a substrate
of Aur-A, we performed in vitro kinase assays with recombinant His-
tagged Coﬁlin and Aur-A (Fig. 1B&C). A radioactive polypeptide band
corresponding to the size of Coﬁlin was detected after incubation withFig. 1. Phosphorylation of Coﬁlin byAuroraA: A:Western blot analysis of PC3 cells treatedwith
Coﬁlin and anti-GAPDH (loading control) antibodies show reduced Coﬁlin phosphorylation a
with recombinant His-Coﬁlin (1 μg) and His-Aurora A (0.22 μg). B: Coomassie stained SDS-PAG
ofHis-Coﬁlin.D& E: Immunocomplex kinase assays of immunoprecipitatedAur-A andHis-Coﬁli
Aur-A antibodies and used in a kinase assay with recombinant His-Coﬁlin. D: Coomassie stained
phosphorylated Coﬁlin.Aur-A (Fig. 1C, lane 3). To further conﬁrm that Coﬁlin is a substrate of
Aur-A, we performed an immunocomplex kinase assay (Fig. 1D&E). En-
dogenous Aur-A was immunoprecipitated from asynchronous PC-3 cell
lysate (500 µg) with anti-Aur-A antibodies and incubated with recom-
binant His-tagged Coﬁlin and γ-32P-ATP (Fig. 1D&E). Results showed
phosphorylation of recombinant Coﬁlin by the immunoprecipitated
Aur-A (Fig. 1E, lane 2). However, our previous studies showed that
LIMK1 co-precipitates with Aur-A so it is possible that the phosphoryla-
tion seen may be due to a combination of both LIMK1 and Aur-A activ-
ities on Coﬁlin [8]. Together, this data conﬁrms that Coﬁlin acts as a
substrate of Aur-A.3.2. Aurora A phosphorylated Coﬁlin at S3, S8, and T25
Coﬁlin activity is regulated by phosphorylation/dephosphorylation
of its main phosphorylation site, S3. To determine if Aur-A phosphory-
lates Coﬁlin at S3, we performed in vitro kinase assays with a
nonphosphorylatable S3A mutant Coﬁlin (CoﬁlinS3A) (Fig. 2A&B).
Phosphorylation of recombinant His-CoﬁlinS3A by His-Aur-A (lane 2)
was reduced compared to phosphorylation of wild-type His-Coﬁlin,
suggesting that S3 is a site of phosphorylation by Aur-A. Because phos-
phorylation of CoﬁlinS3A was reduced compared to wild-type Coﬁlin
but not eliminated, it can be speculated that Aur-A phosphorylates
Coﬁlin at additional residue(s). To identify the additional sites of phos-
phorylation, we performed phosphopeptide analysis of recombinant
wild type full-length Coﬁlin subjected to in vitro non-radioactive kinase
assays with recombinant wild type His-tagged Aur-A or catalytically
inactive His-Aur-AK162M. Mass spectrometric analysis detected two
phosphopeptides containing the phosphorylated residues S3, S8, and T25
in the sample incubated with active Aur-A (Fig. 2C). Phosphorylation
at these sites was not detected in the sample incubated with inactive
Aur-AK162M (data not shown). To conﬁrm these results, we expressed
recombinant His-tagged triple mutant Coﬁlin (CoﬁlinS3A/S8A/T25A) in
which these three residues were mutated to alanine and used foreither DMSOor BMS-5 (5 μM) (LIMK1/2 inhibitor) for 24 h. Immunoblottingwith anti-pS3-
fter treatment with BMS-5 compared to the DMSO control. B & C: In vitro kinase assays
E showing the location of polypeptide bands. C: Autoradiogram showing phosphorylation
n (1 μg). AuroraAwas immunoprecipitated fromPC3whole cell lysates (500 µg)with anti-
SDS-PAGE showing the location and loading of Coﬁlin polypeptides. E: Autoradiogram of
Fig. 2. Aurora A phosphorylated Coﬁlin at speciﬁc sites: A & B: In vitro kinase assays with recombinant His-Coﬁlin, His-CoﬁlinS3A mutant, and His-Aur-A. A: Coomassie stained SDS-PAGE
showing protein location and loading. B: Autoradiogram showing reduced phosphorylation ofHis-CoﬁlinS3A compared toHis-Coﬁlin. C: Phosphopeptide analysis of phosphorylated Coﬁlin
by mass spectroscopy. Two phosphopeptides were detected containing a total of three sites phosphorylated by Aur-A. D & E: In vitro kinase assays of recombinant wild type His-Coﬁlin
and His-CoﬁlinS3A, His-CoﬁlinS3A/S8A/T25A, and His-Coﬁlin90–166 mutants using His-Aurora A or His-Aurora AK162M mutant. D: Coomassie stained SDS-PAGE showing protein location and
loading. E: Autoradiogram showing phosphorylation of His-Coﬁlin, His-CoﬁlinS3A, and His-CoﬁlinS3A/S8A/T25A. No phosphorylation of His-Coﬁlin90–166 could be detected.
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phorylated by Aur-A (Fig. 2E, lane 3), which was not detected when
incubated with inactive Aur-AK162M (lane 7). Phosphorylation of
CoﬁlinS3A/S8A/T25A by Aur-A was reduced compared to phosphorylation
of CoﬁlinS3A, suggesting that these sites are phosphorylated by Aur-A
but additional site(s) may also be phosphorylated by Aur-A. To broadly
identify Coﬁlin fragments containing other possible phosphorylation
sites, we expressed recombinant His-tagged C-terminal fragment of
Coﬁlin containing amino acids 90–166 (Coﬁlin90–166) and used for
in vitro kinase assays. Our results showed that Coﬁlin90–166 was not
phosphorylated by Aur-A (Fig. 2E, lane 4), suggesting that putative ad-
ditional phosphorylation sites in Coﬁlin are between amino acids 1–89.
Other than S3, S8, and T25, possible additional phosphorylation sites
within this region are S23, S24, S41, T63, T70, and T88 (Supplemental
Fig. 1).3.3. Phosphorylation by Aurora A reduced the actin depolymerizing activity
of Coﬁlin
To examine the effect of phosphorylation of Coﬁlin by Aur-A on its
actin modulatory function, we performed actin polymerization assays
to assess the functional status of Coﬁlin. Wild-type recombinant His-
Coﬁlin depolymerized F-actin as reduced Phalloidin staining and
reduced lengths of F-actin were noted compared to the actin only
control (Fig. 3A). Next, we examined the depolymerizing activity of
His-Coﬁlin, His-CoﬁlinS3A, and His-CoﬁlinS3A/S8A/T25A after phosphory-
lation by His-Aur-A (Fig. 3B&C). His-Coﬁlin incubated with inactive
His-Aur-AK162M was more active than His-Coﬁlin incubated with
His-Aur-A as noted by the reduced length of F-actin and the reduced
intensity of Phalloidin staining. Phosphorylation of His-CoﬁlinS3A by
His-Aur-A reduced its activity compared to His-CoﬁlinS3A incubatedwith His-Aur-AK162M. Additionally, His-CoﬁlinS3A/S8A/T25A incubated
with His-Aur-A was signiﬁcantly more active than His-CoﬁlinS3A incu-
batedwith Aur-A, suggesting that phosphorylation at S8 or T25may reg-
ulate Coﬁlin activity. Together, this data suggests that phosphorylation
by Aur-A negatively regulates Coﬁlin activity via phosphorylation.
3.4. Inhibition of Aurora kinases decreased the distribution of F-actin
Next, we wanted to examine the effect of Aurora A activity on actin
polymerization in vivo. MCF7 cells were treated with the pan-Aurora
inhibitor, VX-680, or the vehicle and F-actin status was monitored by
staining with Phalloidin (Fig. 4A–C). The mean intensity of F-actin was
reduced to ~50% in cells treatedwith VX-680 compared to vehicle treat-
ed cells. This data suggests that actin depolymerizing activity of Coﬁlin
was higher in cells treated with VX-680.
3.5. Mutation of Aurora A phosphorylation sites on Coﬁlin caused
mislocalization of Coﬁlin
To examine the effect of phosphorylation at S3, S8, and T25 by
Aur-A we prepared a mammalian expression construct of non-
phosphorylatable RFP-tagged Coﬁlin inwhich all three phosphorylation
sites weremutated to alanines (CoﬁlinS3A/S8A/T25A-RFP). M12 cells were
transfected with either wild type RFP-tagged Coﬁlin (Coﬁlin-RFP)
(Fig. 5A) or RFP-tagged CoﬁlinS3A/S8A/T25A (Fig. 5B) for 48 h. In cells ex-
pressing lower amounts of Coﬁlin-RFP (top panel), Coﬁlin-RFP localized
primarily to the perinuclear region (white arrows). In cells expressing
higher amounts of Coﬁlin-RFP (bottom panel), the expressed protein
was also localized throughout the cell although in some areas accumu-
lation of Coﬁlin-RFP could be seen. CoﬁlinS3A/S8A/T25A-RFP, however,
did not show speciﬁc localization to the perinuclear region (Fig. 5B).
Fig. 3. Phosphorylation by Aurora A reduced actin depolymerizing activity of Coﬁlin: A: Images showing the depolymerization of actin by Coﬁlin. Decreased Phalloidin staining of F-actin
could be noted in the presence of His-Coﬁlin. B: Recombinant His-Coﬁlin, His-CoﬁlinS3A, or His-CoﬁlinS3A/S8A/T25A mutants were in vitro phosphorylated by His-Aur-AK162M (top panels) or
His-Aur-A (bottompanels) and incubatedwith polymerized actin and stainedwith Phalloidin. C:Quantiﬁcation of actinﬁlament length fromB. Incubationwith phosphorylatedHis-Coﬁlin
or His-CoﬁlinS3A mutant by inactive Aur-A reduced Phalloidin staining compared to His-Coﬁlin or His-CoﬁlinS3A phosphorylatedwith active Aur-A. Incubationwith phosphorylated
His-CoﬁlinS3A/S8A/T25A by active Aur-A partially retained Coﬁlin activity as noted by shorter fragments of Phalloidin stained F actin compared to His-Coﬁlin or His-CoﬁlinS3A. Data is
representative of ten longest actin ﬁlaments each in 15 ﬁelds of two independent experiments. Scale bar: 25 μm, *p b 0.05.
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showed punctate localization of the expressed Coﬁlin throughout the
cytoplasm while in cells with higher amounts of expressed protein
(bottom panel), diffuse localization of CoﬁlinS3A/S8A/T25A-RFP through-
out the cytoplasm could be noted. Both proteins colocalized with F-
actin (yellow arrows), but to a lesser extent for CoﬁlinS3A/S8A/T25A-RFP.
This data suggests that phosphorylation by Aur-A regulates subcellular
localization of Coﬁlin.
3.6. Aurora A physically associates with Coﬁlin during mitosis
Aur-A is primarily expressed from late G2 throughoutmitosis. In our
next experiment, we wanted to examine if Aur-A and Coﬁlin interact
during mitosis. M12 cells synchronized at the G2/M boundary were
isolated by shake off and released into mitosis for 0, 30, and 60 min.
Aur-A was immunoprecipitated from mitotic cell extracts using anti-
Aur-A antibodies and co-precipitated Coﬁlin was detected by immuno-
blotting. Coﬁlin was precipitated equally in all time points, which
suggests that Coﬁlin and Aur-A interact throughout the early mitotic
phases (Fig. 6A). The interaction was conﬁrmed using NIH-3T3 cell
extracts in which Coﬁlin was precipitated with Aur-A in all time points
(Fig. 6B). Speciﬁcity of the antibodies was detected by immuno-
precipitating Coﬁlin and Aurora from nocodazole treated extracts.
Immunoprecipitated antigens were detected by immunoblotting with
anti-Coﬁlin or anti-Aurora A antibodies (Supplemental Fig. 2). This
result suggests that Aur-A may play a role in the regulation of Coﬁlin
activity during mitosis.3.7. Inhibition of Aurora A activity altered Coﬁlin phosphorylation
during mitosis
Next, we examined the association of Aur-A catalytic activity with
Coﬁlin phosphorylation during mitosis. M12 cells were treated with
the Aur-A speciﬁc inhibitor, MLN8237, or DMSO and synchronized at
the G2/M boundary with nocodazole. Mitotic cells were collected and
released for 0, 30, and 60 min. Phosphorylated Coﬁlin (pS3) and total
Coﬁlin were detected in mitotic cell extracts by immunoblotting
(Fig. 7A&B). Total Coﬁlin levels in DMSO and MLN8237 treated cells
remained relatively constant in all time points but phospho-Coﬁlin
levels ﬂuctuated. In DMSO treated cells, Coﬁlin phosphorylation was
highest at 30 min (~1.5-fold increase compared to 0 h) and barely
detectable at 60 min (~0.5-fold decrease compared to 0 h). This is in
support of an earlier study showing Coﬁlin phosphorylation during
mitosis [30]. Interestingly, MLN8237 treated cells had low levels of
phospho-Coﬁlin at 0 h, but a N4-fold increased level at 30 and 60 min.
Total Coﬁlin decreased slightly at 30 and 60 min in MLN8237 treated
cells compared to DMSO treated cells (Fig. 7C). MLN8237 treated cells
contained ~70% less phospho-Coﬁlin compared to DMSO treated cells
at 0 h (Fig. 7C). From 0 to 30 min, Coﬁlin phosphorylation increased
~4-fold in MLN8237 treated cells to a level about equal to that in
DMSO treated cells. However, between 30 and 60min Coﬁlin phosphor-
ylation in DMSO treated cells decreased while phosphorylation in
MLN8237 treated cells did not change, causing ~2.5-fold difference in
phosphorylation between the two treatments. This data suggests that
Aur-A plays a role in the regulation of Coﬁlin activity during mitosis.
Fig. 4. Inhibition of Aurora kinases reduced the levels of F-actin. A: Immunoﬂuorescence analysis ofMCF7 cells treatedwith either VX-680 (100 nM) or DMSO for 24 h. F-actin (green)was
visualized by staining with Phalloidin. DNAwas stained with DAPI (blue). B: Phalloidin staining from cells in A was imaged after increasing exposure time to show actin staining in detail
within the cell. C: Quantitation of the mean intensity of Phalloidin staining. Data is representative of 150 cells from two independent experiments. Scale bar: 10 μm.
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mitotic stage, we expressed RFP-tagged phosphomimic mutant of
Coﬁlin (CoﬁlinS3EE) in M12 cells. Cells were transfected in nocodazole
containing medium, incubated for 24 h and released for 30 min. A dis-
tinct difference in sub-cellular localization of CoﬁlinS3EE-RFP (inactive)
compared to the wild type Coﬁlin-RFP was noted in the early mitotic
stage. The cells expressing wild type Coﬁlin-RFP showed a punctate
staining at the periphery, while the distribution of CoﬁlinS3EE-RFP is
more homogeneous (Fig. 7D, Supplemental Fig. 3). Differential targeting
of phospho-Coﬁlin may have implication in altered actin dynamics in
the early mitotic stages.
To coordinate the mitotic phases with Coﬁlin phosphorylation, we
evaluated the stages of mitosis in MLN8237 treated cells as Aur-A
inhibition has been shown to cause amitotic delay [10].We used immu-
noﬂuorescence analysis to quantify the distribution of cells released in
fresh medium in each mitotic phase at each time point in MLN8237
treated cells (Fig. 8A–D, Supplemental Fig. 4 and Tables S1 & S2).
DMSO treated cells had a higher percentage of cells in mitosis (~40%
at each time point) compared to MLN8237 treated cells (~20% of cells
at each time point) (Fig. 8C and Table S1). In DMSO treated cells,
quantitative analysis of mitotic phases in DMSO treated cells showed
that ~30.2%, ~68.48%, ~1.86%, and 0% of cells were in prophase, meta-
phase, anaphase, and telophase respectively, at 30 min. At 60 min,
cells progressed to anaphase and telophase as evident from ~25.41%,
~59.61%, ~7.93%, and ~7.06% of cells in prophase, metaphase, anaphase,
and telophase, respectively (Fig. 8D & Table S2). Treatment with Aur-A
inhibitor caused a delay in mitotic progression as evident from ~77.54%
and ~22.46% of cells at 30 min and ~78.34% and ~19.84% of cells at
60 min in prophase and metaphase, respectively. No cells in anaphaseor telophasewere noted at 60min. This data suggests that the alteration
of Coﬁlin phosphorylation and phospho-Coﬁlin localization may be
associated with the mitotic delay induced by the inhibition of Aur-A
activity.
3.8. Inhibition of Aurora A activity altered Slingshot-1 expression during
mitosis
It has been shown that overexpression of Aur-A can increase the
expression of Slingshot-1 phosphatase (SSH-1) [14]. Hence, we wanted
to examine if inhibition of Aur-A altered expression of SSH-1. M12 cells
were treated with either MLN8237 or DMSO and synchronized to the
G2/M boundary with nocodazole. Mitotic cells were isolated by mitotic
shake off and released into mitosis with fresh media containing either
MLN8237 or DMSO. SSH-1 expression was detected in mitotic extracts
by immunoblotting (Fig. 9A&B). In DMSO treated cells, SSH-1 expres-
sion increased through 60 min. SSH-1 expression in MLN8237 treated
cells followed a similar trend but expression was signiﬁcantly lower in
all time points compared to DMSO treated cells. Together, this data con-
ﬁrms that Aur-A modulates SSH-1 expression during early mitotic
phases.
3.9. Both Aurora A and LIMK1 contribute to Coﬁlin phosphorylation in the
early mitotic phase
Recently, a bidirectional functional relationship between Aur-A and
LIMK1 during mitosis has been demonstrated [8]. Earlier it was shown
that LIMK1 phosphorylates Coﬁlin during mitosis [31]. To determine
the contribution of LIMK1/2 in maintaining phospho-Coﬁlin levels
Fig. 5.Mutation of Aurora A phosphorylation sites resulted in themislocalization of Coﬁlin: Fluorescencemicroscopy ofM12 cells transfectedwith Coﬁlin-RFP (A) or CoﬁlinS3A/S8A/T25A-RFP
(B). F-actin was stained with Phalloidin-488 (green) and DNA was stained with DAPI (blue). Coﬁlin-RFP localized to the perinuclear region (white arrows) while CoﬁlinS3A/S8A/T25A-RFP
showed diffuse staining throughout the cell. Colocalization of the wild type Coﬁlin and the mutant Coﬁlin with F-actin could be noted (yellow arrows). Scale bar: 10 μm. Top panel:
cells expressing lower amounts of Coﬁlin RFP or CoﬁlinS3A/S8A/T25A-RFP; bottom panel: cells expressing higher amounts of Coﬁlin-RFP or CoﬁlinS3A/S8A/T25A-RFP.
Fig. 6. Interaction of Aurora A with Coﬁlin during mitosis: Coimmunoprecipitation of
Coﬁlin with Aur-A in nocodazole treatedM12 or NIH-3T3 cell extracts harvested at differ-
ent times after release. Aur-A was immunoprecipitated using anti-Aurora A antibodies,
and Coﬁlin was detected by immunoblotting using anti-Coﬁlin antibodies. Mouse IgG
was used as a control. Data represents the results of three independent experiments.
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inhibitor BMS-5 on Coﬁlin phosphorylation by western blot analysis.
We noted a signiﬁcant reduction in phospho-Coﬁlin (pS3) levels in all
timepoints in releasedM12 cells treatedwithBMS-5,whichwas further
reduced to undetectable levels upon combination treatment of BMS-5
and MLN8237 (Fig. 7E). Because Aur-A phosphorylates and activates
LIMK1 [8], we examined the activation status of LIMK1 during mitosis
in cells treated with MLN8237. It could be noted from our results that
phosphorylated LIMK1/2 was barely detectable in DMSO treated cells
but was undetectable in MLN8237 treated cells (Supplemental Fig. 5).
Since, low levels of pLIMK1/2 were detected in DMSO treated cells it is
more likely that pLIMK1/2 is further lowered in MLN8237 treated cells
rather than completely absent. Together, this data suggests that both
LIMK and Aur-A participate in the regulation of Coﬁlin phosphorylation
during mitosis.
4. Discussion
In this study, we show a novel interaction between Aur-A and
Coﬁlin. Our study identiﬁed that Coﬁlin acts as a substrate of Aur-A,
which phosphorylates Coﬁlin at multiple sites including S3, S8, and T25.
Phosphorylation at S3 renders Coﬁlin inactive by blocking its binding
to actin. Therefore, one role of Aur-A phosphorylation is to regulate
the activity of Coﬁlin. Serine8 phosphorylation has been mentioned in
two proteomics studies [32,33] but has never been experimentally
conﬁrmed therefore, the consequence of this phosphorylation is un-
known. Threonine25 phosphorylation has also been noted in a number
Fig. 7. Inhibition of Aurora A activity altered Coﬁlin phosphorylation and phospho-Coﬁlin showed differential targeting in the mitotic cells: Western blot analysis of endogenous
Coﬁlin (A) and phospho-Coﬁlin (pS3) (B) in nocodazole treated M12 cell extracts released at different times with treatment with MLN8237 (100 nM) or the vehicle. Anti-Coﬁlin and
anti-phospho-Coﬁlin antibodies were used for the immunoblots. GAPDH expression was used as the loading control. Values below each ﬁgure indicates relative protein levels normalized
to 0 minute expression (not released from G2/M boundary). C: Densitometric analysis of Coﬁlin and phospho-Coﬁlin in MLN8237 treated cells compared to DMSO treated cells. Data
shows mean ± SD of three independent experiments. D: Localization of CoﬁlinS3EE-RFP and Coﬁlin-RFP in nocodazole synchronized M12 cells released for 30 min. Spindle α-tubulin
(green) was visualized by staining with anti-α-tubulin antibodies. DNA was stained with DAPI (blue). Coﬁlin-RFP showed a distinct punctate localization at the cell periphery whereas
CoﬁlinS3EE-RFP distributionwas homogeneous surrounding the DNA at the earlymitotic stages. Scale bar: 10 μm. E:Western blot analysis of pS3-Coﬁlin in extracts of nocodazole synchro-
nizedM12 cells treatedwith BMS-5 (5 μM) singly or in combinationwithMLN8237 (100 nM) using anti-pS3-Coﬁlin antibodies. Cells were released intomitosis and harvested at different
times. GAPDH expression was used as the loading control Lys: untreated whole cell lysate. Data is representative of at least three independent experiments.
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study [36], but the function of this phosphorylation is also unknown.
In vitro phosphorylation of the CoﬁlinS3A/S8A/T25A mutant suggested
additional residues are phosphorylated by Aur-A. Because the C-
terminal fragment of Coﬁlin (residues 90–166) was not phosphorylated
by Aur-A, the additional phosphorylation sites most likely lie between
amino acids 1–89. Two putative residues are S23 and S24 (RKSST) be-
cause they share a partial homology with the Aur-A phosphorylation
motif ([K/N/R]-R-X-[pS/pT]-V) with a bias at the n + 1 position. Inter-
estingly the phosphorylation motif of Aur-A maintains that the n + 1
position must not be a proline residue while T25 precedes a proline
residue. Additionally, T63 and T70 may be phosphorylated by Aur-A but
their phosphorylation would not have been detected by mass spectros-
copy because the tryptic digestion would not have produced a peptide
containing these residues. Serine41 and T88 are two residues that could
have been the additional phosphorylation sites but were not detected
by mass spectrometry.
Phosphorylation by Aur-A negatively regulates Coﬁlin activity as
noted in actin polymerization assays. Phosphorylation at S3 inactivates
Coﬁlin by preventing its ability to bind actin ﬁlaments. Therefore, re-
duced actin depolymerization by wild-type recombinant Coﬁlin incu-
bated with His-Aur-A may be due to phosphorylation speciﬁcally at
this site. Importantly, His-CoﬁlinS3A activitywas also noticeably reduced
upon phosphorylation by His-Aur-A, while His-CoﬁlinS3A/S8A/T25A
retained a signiﬁcantly higher level of activity when incubated
with His-Aur-A. This data suggests that phosphorylation at residuesin addition to S3 are involved in the regulation of the depolymerization
activity of Coﬁlin. Since S8 is in close proximity to S3, phosphorylation
at that site may result in a similar conformational change that
would prevent binding to actin. Inhibition of Aur-A activity was also
correlated with the reduced levels of F-actin in vivo. Taken together,
it is likely that the alteration in F-actin by Aur-A was mediated
through Coﬁlin.
Aur-A phosphorylation of Coﬁlin also inﬂuences intracellular locali-
zation of Coﬁlin. Wild type Coﬁlin-RFP and CoﬁlinS3A/S8A/T25A-RFP
showed distinct differences in subcellular localization. Coﬁlin has been
reported to localize to the Golgi to aid in cargo sorting and fusion of
carrier vesicles [37–39]. Aur-A may regulate Coﬁlin localization to this
area through phosphorylation.
Our results also showed that Aur-A and Coﬁlin interact duringmito-
sis and that this interaction is maintained during mitotic progression
from prophase to telophase. However, the activation status of Coﬁlin
through phosphorylation changes as cells progress through the mitotic
phases. Phospho-Coﬁlin levels are at the peak when cells are mostly in
prophase and metaphase but declined signiﬁcantly as the cells start to
progress to anaphase. It can be speculated that actin depolymerization
is required as the spindles start to change shape and elongate during
anaphase possibly through interaction with cortical actin. Interestingly,
inhibition of Aur-A activity resulted in a sustained increase in phospho-
Coﬁlin levels, which is counterintuitive of decreased phospho-Coﬁlin as
a result of the inactivation of Aur-A. Importantly, MLN8237 treated cells
showed a delayed progression of mitosis, as themajority of the cells are
Fig. 8. Treatmentwith Aur-A inhibitor delayed progression of cells through prophase: Immunoﬂuorescence analysis of DMSO (A) or MLN8237 (100 nM) (B) treated and nocodazole syn-
chronized M12 cells released into mitosis for 0, 30, or 60 min. α-Tubulin (green) and Coﬁlin (red) were visualized by staining with anti-α-tubulin and anti-Coﬁlin antibodies. DNA was
stainedwithDAPI (blue).Mitotic cells presented are enlarged images fromSupplemental Fig. 4. C:Quantitation of the percent of cells in interphase ormitosis. Data shows averagenumbers
of cells counted in 20 ﬁelds each from two separate experiments. D: Quantitation of the percent of cells in eachmitotic phase. Data shows average numbers of cells counted in 20 random
ﬁelds each from two separate experiments. Scale bar: 5 μm.
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speculated that inhibition of Aur-A activity induced mitotic delay is
partly mediated by the failure of Coﬁlin-mediated depolymerization of
actin. A differential localization of phosphomimic Coﬁlin at this stage
is also indicative of altered actin dynamics. However, the question that
we ask is how phospho-Coﬁlin levels increased upon inhibition of
Aur-A kinase activity. We speculate that LIMK1 and SSH-1 phosphatase
mediated Coﬁlin phosphorylation/dephosphorylation is responsible for
the optimumphospho-Coﬁlin levels duringmitosis.Wehave previously
reported that Aur-A phosphorylates LIMK1 during mitosis, activating
the protein and regulating its localization to the centrosomes [8]. An
earlier report showed that Aur-A regulates SSH-1 expression, as Aur-A
overexpression led to increased expression of SSH-1 and dephosphory-
lation of Coﬁlin in asynchronous cells [14]. Our data support this ﬁnding
as SSH-1 expression was signiﬁcantly reduced after treatment with
MLN8237. Earlier studies indicated that the regulation of Coﬁlin phos-
phorylation is essential for cytokinesis as the accumulation of F-actin
during late mitotic stages can cause cytokinesis defects leading to mul-
tinucleate cells [40]. Overexpression of LIMK1 also led to cytokinesis de-
fects through enhanced F-actin via the inactivation of Coﬁlin [41].
Additionally, overexpression of a phosphatase inactive SSH1 mutantcaused cytokinesis defects through increased levels of phospho-Coﬁlin
and F-actin enhancement [31]. Our study demonstrates that the regula-
tion of Coﬁlin phosphorylation is also important for the progression of
early mitotic phases.
Based on these observations we propose a Coﬁlin phosphorylation
model during mitosis (Fig. 10). In early mitotic phases, LIMK1 and
Aur-A phosphorylate and inactivate Coﬁlin (Fig. 10D&A) while at the
later stages SSH-1 inactivates LIMK1 by removing the phosphate
group at T508 [42] (Fig. 10G), and additionally, dephosphorylates and ac-
tivates Coﬁlin (Fig. 10F) [31]. Aur-A being a key regulator of earlymitot-
ic phases is participating in maintenance of phospho-Coﬁlin levels
through the activation of LIMK1, and SSH-1 as a negative feedback
loop (Fig. 10B&E), which possibly resulted in decreased phospho-
Coﬁlin levels as cells start to progress to anaphase. It can be speculated
that increased phosphorylation/inactivation of Coﬁlin following inhibi-
tion of Aur-A activity by MLN8237 treatment may be linked with de-
creased levels of SSH-1 (Fig. 10E&F). Earlier studies showed that
LIMK1 dependent phosphorylation of Coﬁlin is necessary for propermi-
totic spindle orientation [28] and that treatment of cells with MLN8237
results in multipolar spindles and abnormal spindle morphology [8]. In
conclusion, our data suggests that Aur-A functions in the early mitotic
Fig. 9. Inhibition of Aurora A activity altered Slingshot-1 expression: A:Western blot anal-
ysis of SSH-1 expression in nocodazole treated M12 extracts released at different times
with treatment of MLN8237 (100 nM) or vehicle. Anti-SSH-1 antibodies were used for
the immunoblots and α-tubulin expression was used as the loading control. B: Densito-
metric analysis of SSH-1 expression inMLN8237 andDMSO treated cells. Data is represen-
tative of at least three independent experiments. *p = b0.05. **p = b0.005.
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and actin polymerization.
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